Editorial: Cancer and inflammatory diseases research: from the basics to the precision medicine

Front Pharmacol. 2024 Aug 27:15:1477963. doi: 10.3389/fphar.2024.1477963. eCollection 2024.

Adriano Sabino¹, Masamitsu Kanada^{2

3

4}, Elaine Leite⁵, Mariana Quezado⁶, Whocely Victor de Castro⁷

¹ Department of Clinical and Toxicological Analysis, Faculty of Pharmacy, Federal University of Minas Gerais, Belo Horizonte, Brazil.
² Institute for Quantitative Health Science and Engineering (IQ), Michigan State University, East Lansing, MI, United States.
³ Department of Pharmacology and Toxicology, Michigan State University, East Lansing, MI, United States.
⁴ College of Human Medicine, Michigan State University, East Lansing, MI, United States.
⁵ Department of Pharmaceutical Products, Faculty of Pharmacy, Federal University of Minas Gerais, Belo Horizonte, Brazil.
⁶ Department of Biochemistry and Immunology, Institute of Biological Sciences, Federal University of Minas Gerais, Belo Horizonte, Brazil.
⁷ Pharmaceutical Sciences Program, Federal University of São João del-Rei, São João del Rei, Brazil.

No abstract available

Keywords: cancer; inflamatory diseases; pharmacology; precision medicine; therapy.

Publication types

The author(s) declare that no financial support was received for the research, authorship, and/or publication of this article.